Tivicay 50 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJK2H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,941
Award facts
- Contract value 100% obligated
- $13,941.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,941.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TIVICAY 50 MG tablets (30-count packaging), with an ultimate completion date of January 28, 2026. This non-set-aside award was competitively procured and reflects a routine pharmaceutical supply transaction within the federal medical supply chain. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal healthcare procurement, particularly for military and veteran medical systems. The company operates as a subsidiary of Cencora, Inc., which maintains the parent organizational relationship within the supply chain.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at up to $999,999,999 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across multiple therapeutic domains. The IDC structure allows DLA to efficiently procure essential medical commodities through flexible task ordering, with this particular order for TIVICAY—an antiretroviral medication—representing one of numerous individual fulfillments under the larger contract vehicle established to support Defense Health Agency operations and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJK2H?
SPE2DR26FJK2H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FJK2H worth?
The government has obligated $13,941 on SPE2DR26FJK2H.
Is contract SPE2DR26FJK2H an order under another contract?
Yes. SPE2DR26FJK2H is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJK2H competed?
The extent of competition for SPE2DR26FJK2H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award